The recent Ebola outbreak in the Democratic Republic of Congo (DRC) has raised serious concerns, with Oxfam warning that the 'first line of defense' against the deadly virus has collapsed. The Bundibugyo strain of Ebola, which has no vaccine or treatment, is causing a devastating impact in the northeastern province of Ituri, with nearly 781 infected and 181 dead. However, the true toll is likely far higher due to the country's strained contact tracing program and water infrastructure.
Manel Rebordosa, Oxfam's field response coordinator, highlights the dire situation in Mongbwalo, a town of 140,000 people, where only two in ten have access to clean water, and a quarter have access to working hygiene facilities. This has forced families to use water contaminated with chemicals from local mines, which is a significant risk factor for the spread of the virus.
The outbreak is particularly concerning due to the lack of a vaccine or treatment for the Bundibugyo strain. The US Centers for Disease Control and Prevention (CDC) has confirmed this is the largest Bundibugyo outbreak on record, and North Kivu province is seeing Ebola cases being identified after the patient has died, unaware they had the illness. Contact tracing, a crucial tool in containing the virus, has only 43% coverage, which is a significant shortcoming.
The years-long violence in the DRC has displaced millions, including people in Ituri, complicating contact tracing efforts. Aid workers have built isolation tents and disinfection stations near hospitals, but locals have burned down these facilities when officials refused to hand over the bodies of the dead over fears the infection could spread. Many now see hospitals as 'death traps' and are turning to traditional health methods, which Rebordosa says is hampering containment.
The US has played a role in the Ebola outbreak, with Rebordosa noting that healthcare workers achieved contact tracing rates of nearly eight in ten in 2018, but today, following the withdrawal of US funding for disease surveillance and severe funding shortfalls, contact tracing is reaching fewer than half of the contacts. This gap allows the virus to spread undetected through communities.
The situation is further complicated by the lack of awareness about Ebola among locals. The illness, caused by a group of related viruses, has two stages: a dry stage with fever, aches, pains, and fatigue, and a wet stage with diarrhea, vomiting, and bleeding. The initial symptoms can resemble the common cold or flu, leading to many cases going undiagnosed.
Despite the dire circumstances, there is some hope. About 25 people have recovered from the virus, and an experimental Bundibugyo vaccine is being developed in the UK by the Oxford Vaccine Group using the same technology used to develop the COVID vaccine. Researchers are working on an accelerated schedule while adhering to established scientific, ethical, and regulatory standards.
In conclusion, the Ebola outbreak in the DRC is a critical public health emergency that requires immediate and sustained action. The collapse of the first line of defense, the strained contact tracing program, and the lack of a vaccine or treatment for the Bundibugyo strain are all contributing to the rapid spread of the virus. It is crucial to address these issues and provide the necessary support to contain the outbreak and prevent further loss of life.
